Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study

V114-018 (PNEU-WAY) study group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences